Global GLP-1 Analogues Market Size & Trends Report Segmented by Product (Ozempic, Mounjaro, Wegovy, Rybelsus, Saxenda), Route of Administration (Subcutaneous, Oral), Application (Diabetes, Obesity), End-user Analysis & Regional Forecast to 2031 The global GLP-1 analogues market size is expected to grow at a CAGR of 14% during the forecast period
There is a time and a place for statin medications, but using them without better consideration of the populations at risk, will result in increased incidence of diabetes, obesity and dementia
Following endogenous growth hormone release, insulin-like growth factor-1 (IGF-1) mediates many downstream physiological processes involved in normal growth hormone biology
In 2024, the Western Pacific had approximately 215 million adults with diabetes, while Southeast Asia accounted for another 106.9 million, creating a vast potential patient pool
The '3' in GLP-3 means it acts on three different receptors at once
Never reuse a vial past its 28-day window, even if it appears clear and unchanged